Skip to main content Skip to main navigation menu Skip to site footer

Relationship between the amount of blood transfusion and the amount of iron chelation with blood and salivary ureum levels in children with beta thalassemia major

Abstract

Introduction: Patients with thalassemia experience a synthesis of one of the beta chains of the globin gene, resulting in reduced hemoglobin formation. Patients with beta-thalassemia major require routine transfusions and iron chelation. Both of these cause impaired kidney function. This study aims to determine the relationship between the amount of blood transfusion and the amount of iron chelation with blood urea and saliva levels in children with beta-thalassemia major.

Methods: An observational cross-sectional study was conducted at Moewardi Hospital, Solo using patients with beta-thalassemia major as subjects, taken by consecutive sampling from September to November 2018. The data on blood transfusion, iron chelation, and blood urea levels were obtained from medical records. Unstimulated saliva was taken in the morning. The urease method was used to assess the salivary urea levels and all data was analyzed using Pearson correlation analysis.

Result: The results showed the mean amount of transfusion was 71.9 ± 34.3, the amount of iron chelation 61.0 ± 32.1, blood urea levels 4.41 ± 1.1 mg / dL, and salivary urea levels 35.6 ± 12.5 mg / dL. Correlation analysis showed a positive correlation between the amount of blood transfusion and the amount of iron chelation with blood and saliva urea levels. There was also a positive correlation between blood urea and saliva levels.

Conclusion: It can be concluded that the amount of blood transfusion and iron chelation affects urea levels in blood and saliva in children with beta-thalassemia major. The close correlation between blood and saliva urea indicates that salivary urea can be used as an alternative assessment of blood urea.

References

  1. Permono - Ugrasena. 2005. Buku Ajar Hematologi-Onkologi Anak, Badan Penerbit IDAI : Jakarta, halaman 242-243.
  2. Moncada G. Salivary Urease and ADS Enzymatic Activity as Endogenous Protection Against Dental Caries in Children , J Clin Pediatr Dent 2015; 39 (4).
  3. Kemenkes RI. Profil Kesehatan Indonesia tahun 2018. Jakarta.
  4. Ali S. M., Ahmed S. Oral and Maxillofacial Manifestations in 50 β – Thalassemic Patients a Clinical Study, The Professional Medical Journal 2016;36 (2) : 179-184.
  5. Saxena A. Growth retardation in Thalassemia Major Patient. Int J Hum Genet 2003, 3(4):237-46.
  6. Pooya A., Karimi M., Immanich. Growth Retardation in Children with Thalassemia Major. Haematology 2004; 7 (4) :493-6.
  7. Rund D., Rachmilewitz E., 2005. Β Thalassemia. N Engl J Med , 353 : 1135-46.
  8. Laksmitawati D., Handayani S., Udyaningsih S., Kurniati V., Adhiyanto C., Hidayat J. Iron Status and Oxidate Stress in Beta Thalassemia Patients in Jakarta. IOS Press 2003: 53-62.
  9. Al-jobouri, H. S. Selected Salivary Constituents Among 16-18 Years Patients with β Thalassemia Major in Relation to Oral Disease, J Bagh College Dentisrty 2011; 23 (2) : 31-34.
  10. Madhok S. Dental Considerations in Thalassemic Patients, Journal of Dental and Medical Sciences 2014; 13 (6) : 57-62.
  11. Dhote V., Thosar N., Baliga S. Evaluation of Oral Hygiene Status and Salivary Biochemistry of Patients with Thalassemia Major : a clinical study , J of Dental and Medical Science 2015; 14 (12) : 98-102.
  12. Lasisi T.J., Raji Y.R., Salako B.L. Salivary Creatinine and Urea Analysis in Patients with Chronic Kidney Disease : a case control study. BMC Nephrol 2016: 1-6.
  13. Casamassimo P.S., Fields H.W., McTigue D.J., Nowak A.J. 2013. Pediatric Dentistry : Infacy Through Adolescence. Elsivier Saunders.
  14. Alessandro, S. N., Sayeeda M., Omana S. Clinical and Diagnostic Utility of Saliva as a Non Invasive Diagnostic Fluid : a systematic review, J of Croation Society of Medical Biochemistry and Laboratory Medicine 2015;25 (2) : 177 – 92.
  15. Fathi FH, Ahmed Y, Alhially H, Yahya A, Bashi D. Evaluation of Conventional Renal Test in Patients with β Thalassemia Major Using Deferasirox , Malaysian Journal of Pharmaceutial Sciences 2013; 11 (2) : 1-9.
  16. Fathi FH, Ahmed Y, Alhially H, Yahya A, Bashi D. Evaluation of Conventional Renal Test in Patients with β Thalassemia Major Using Deferasirox , Malaysian Journal of Pharmaceutial Sciences 2013; 11(2): 1-9.
  17. Goli S., Alaparthi R.K., Yalamanchili S., Nunsavathu P.N., Ambaldhage V.K. Analysis of blood and salivary urea levels in patients undergoing haemodialysis and kidney transplant , J Clin Diagn Res 2014;8:18–20.
  18. Gemella N., Illahi, Rudin T., Rasmidar S. Concentration of Total Protein and Degree of Acidity (pH) of Saliva when Fasting and After Breakfasting, J of Dentomaxillofacial Science 2016;1: 36-38.
  19. Mallat N.S., Mallat S.G., Musallam K.M. Potential Mechanisms for Renal Damage in Beta Thalassemia , JNephrol 2013;26(10): 821-828.
  20. Dubey S., 2008. Perdarahan Gastrointestinal Atas. In : Greenberg M, Teks Atlas Kedokteran Kedaruratan. Greenberg Vol I. Jakarta : Publisher Erlangga ; 275.
  21. Hockenberry M.J., Wilson D., 2009. Essential of Pediatric Nursing. St. Louis Missoury : Mosby.
  22. Greenberg M.S., Glick M., Ship JA, 2008. Burket’s oral medicine. 11th ed. Hamilton : BC Decker Inc , h.97.
  23. Dubourg L., Laurain C., Ranchin B et al. Deferasirox Induced Renal Impairment in Children : An Increasing Concern For Pediatricians , Pediatr Nephrol 2012; 2115 – 2122.
  24. Pfaffe T., Cooper-White J., Beyerlein P., Kostner K., Punyadeera C. Diagnostic Potential of Saliva: Current State and Future Applications. Clin Chem 201; 57: 675–87.

How to Cite

Pradypta, P. G., Titien, I., & WM, P. K. (2022). Relationship between the amount of blood transfusion and the amount of iron chelation with blood and salivary ureum levels in children with beta thalassemia major. Bali Medical Journal, 11(3), 2043–2047. https://doi.org/10.15562/bmj.v11i3.3488

HTML
2

Total
2

Share

Search Panel